Literature DB >> 7585546

Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR.

Q Wei1, X Xu, L Cheng, R J Legerski, F Ali-Osman.   

Abstract

We describe here the development, optimization, and use of a non-radioactive, quantitative, multiplex reverse transcriptase-PCR technique to measure, in a single reaction, the relative levels of the transcripts of four DNA repair genes (XPCC, hMSH2, XRCC1, and ERCC1) and the beta-actin gene in lymphoblastoid cell lines and frozen peripheral blood lymphocytes. Expression of defective DNA repair genes was not detected in DNA repair-deficient human cell lines, whereas the intact genes were detected in repair-proficient cell lines and in lymphocytes from a normal donor. The assay was reproducible, and repeated determinations of the same samples generated highly consistent results for each target gene. This approach should facilitate molecular epidemiological studies that incorporate screening for germline alterations that may affect gene expression and for changes in the levels of gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585546

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Prognostic significance of CDC25B expression in gliomas.

Authors:  H Nakabayashi; M Hara; K Shimizu
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

2.  Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

Authors:  Y E Whang; X Wu; H Suzuki; R E Reiter; C Tran; R L Vessella; J W Said; W B Isaacs; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.

Authors:  H Kobayashi; Y Takemura; H Miyachi; M Kawabata; S Mori; Y Kawai; K Furihata; S Sekiguchi; K Watanabe
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Expression of DDB2 Protein in the Initiation, Progression, and Prognosis of Colorectal Cancer.

Authors:  Huaiwei Yang; Jingwei Liu; Jingjing Jing; Zeyang Wang; Yi Li; Kaihua Gou; Xue Feng; Yuan Yuan; Chengzhong Xing
Journal:  Dig Dis Sci       Date:  2018-07-27       Impact factor: 3.199

Review 5.  DNA repair phenotype and cancer susceptibility--a mini review.

Authors:  Chunying Li; Li-E Wang; Qingyi Wei
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

6.  Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.

Authors:  Mona Saebø; Camilla Furu Skjelbred; Bjørn Andersen Nexø; Håkan Wallin; Inger-Lise Hansteen; Ulla Vogel; Elin H Kure
Journal:  BMC Cancer       Date:  2006-08-16       Impact factor: 4.430

7.  Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways.

Authors:  Y Minagawa; J Kigawa; H Itamochi; Y Kanamori; M Shimada; M Takahashi; N Terakawa
Journal:  Jpn J Cancer Res       Date:  1999-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.